Zurich, Switzerland

Tamas Mallat

This inventor holds 3 USPTO granted patents. Top assignees: Lonza Ag, Roche Vitamins Inc.. Active years: 2002-2003.


% Patents Active = 66.7

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2002-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Tamas Mallat: Innovator in Catalytic Processes

Introduction

Tamas Mallat is a distinguished inventor based in Zurich, Switzerland. He has made significant contributions to the field of chemistry, particularly in the area of catalytic processes. With a total of 3 patents to his name, Mallat's work has had a notable impact on various industrial applications.

Latest Patents

One of his latest patents is titled "Continuous process for the enantioselective hydrogenation of alpha ketocarbonyl compounds." This invention relates to a continuous process for enantioselective catalytic hydrogenation of alpha ketocarbonyl compounds, such as alpha ketoesters and alpha ketolactones, to produce alpha hydroxy carbonyl compounds. Another significant patent is "Process for the preparation of amines," which showcases his innovative approach to chemical synthesis.

Career Highlights

Throughout his career, Tamas Mallat has worked with prominent companies in the industry, including Lonza AG and Roche Vitamins Inc. His expertise in catalytic processes has been instrumental in advancing the capabilities of these organizations.

Collaborations

Mallat has collaborated with notable professionals in his field, including Alfons Baiker and Achim Fischer. These partnerships have further enriched his research and development efforts.

Conclusion

Tamas Mallat's contributions to the field of chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in catalytic processes and chemical synthesis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…